Donald J. Trump will become the 47th president of the United States.

This is a special bonus episode of Squawk Pod from CNBC. We're bringing you over two hours of our 2025 inauguration coverage.

Becky Quick is in Washington, D.C. with a litany of guests, investors,

Washington insiders, and CEOs like Pfizer's Albert Borla, on the realistic hurdles ahead and

the opportunity. But there are things that Kennedy says that we can work with, and I don't see

why you wouldn't be able to create together something on cancer,

for example.

The business angles you need to know as Donald Trump takes office as the 47th president

of the United States. Investor Stanley Druckenmiller joins us.

CEOs are somewhere between relieved and giddy. We're a believer in animal spirits.

And the executive orders we can expect after he's sworn in,

with special reporting from CNBC's Aymn Javers.

We watch the pageantry, the parades, the celebration today.

There is substance on the line, and there is an underlying tension here.

I'm CNBC producer Cameron Costa.

It's January 20th, 2025, and Squawk Pod's special bonus episode of the inauguration

of Donald J. Trump begins right now.

Good morning, everyone, and welcome to CNBC's special coverage of the inauguration of Donald J. Trump.

I'm Becky Quick, live from Washington, D.C.

Over the next several hours, we will show you the transition of power from President Biden to President Trump.

We have a huge lineup of guests joining us today, including the CEO of Pfizer, legendary investors, Stan Druckamiller, Carlisle's David Rubinstein, and Elon Musk's biographer Walter Isaacson.

We're going to look at this from every angle, what it means for you and your money.

...